Literature DB >> 422224

Multiple effects of a diamidine (propamidine) on complement activation.

W Vogt, B Hinsch, G Schmidt, I Von Zabern.   

Abstract

Propamidine, one of the diamidines used against infections with babesiae has inhibitory and enhancing effects on complement activation as assessed by immune haemolysis of sensitized sheep red cells. Utilization of C1 is powerfully, that of C3 weakly improved by propamidine while activation and/or fixation of C4, C5 and to a lesser degree of C8 and C9 are inhibited. At low concentrations of propamidine (less than 2 mM) the enhancing effects, at higher concentrations the inhibitory effects predominate. Inhibition is produced, in some cases certainly, in others likely, by interference of propamidine with binding properties of complement components. None of the complement enzymes, C1s, C42 or C3bBb was inhibited in its hydrolytic activity. The possible significance of propamidine actions is discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 422224      PMCID: PMC1457391     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  9 in total

1.  The unactivated form of the first component of human complement, C1.

Authors:  I Gigli; R R Porter; R B Sim
Journal:  Biochem J       Date:  1976-09-01       Impact factor: 3.857

2.  The isolation and structure of C4, the fourth component of human complement.

Authors:  I Gigli; I von Zabern; R R Porter
Journal:  Biochem J       Date:  1977-09-01       Impact factor: 3.857

3.  The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway.

Authors:  V Brade; G D Lee; A Nicholson; H S Shin; M M Mayer
Journal:  J Immunol       Date:  1973-11       Impact factor: 5.422

4.  Interaction of the B-determinant of the third component of complement with amidino compounds.

Authors:  S S Asghar; R H Cormane
Journal:  Immunochemistry       Date:  1976-12

5.  Interference of propamidine with binding of the fifth component of complement to surface-fixed C3b, and with C5 activation.

Authors:  W Vogt; G Schmidt; B Hinsch
Journal:  Immunology       Date:  1979-01       Impact factor: 7.397

6.  Changes in antigenic properties of human C3 upon activation and conversion by trypsin.

Authors:  J L Molenaar; M A Müller; C P Engelfriet; K W Pondman
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

7.  Purification and some properties of a heat labile serum factor (UP); identity with glycine-rich beta-glycoprotein and properdin factor B.

Authors:  R Lynen; V Brade; A Wolf; W Vogt
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1973-01

8.  Purification and some properties of factor D of the human properdin system.

Authors:  L Dieminger; W Vogt; R Lynen
Journal:  Z Immunitatsforsch Immunobiol       Date:  1976-11

9.  Enharncement of the hemolytic activity of the second component of human complement by oxidation.

Authors:  M J Polley; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1967-12-01       Impact factor: 14.307

  9 in total
  1 in total

1.  Interference of propamidine with binding of the fifth component of complement to surface-fixed C3b, and with C5 activation.

Authors:  W Vogt; G Schmidt; B Hinsch
Journal:  Immunology       Date:  1979-01       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.